Силодозин новый препарат группы селективных А1-адреноблокаторов
Автор: Яровой С.К.
Журнал: Экспериментальная и клиническая урология @ecuro
Рубрика: Организация урологической помощи
Статья в выпуске: 3, 2012 года.
Бесплатный доступ
Доброкачественная гиперплазия предстательной железы, а-адреноблокаторы, силодозин, уроселективность
Короткий адрес: https://sciup.org/142188321
IDR: 142188321
Список литературы Силодозин новый препарат группы селективных А1-адреноблокаторов
- Morishima S., Suzuki F., Nishimune A. Visualization and tissue distribution of a1-adrenoceptor in human prostate by the fluorescently labeled ligand Alexa-488-silodosin.//J. Urol., 2009. Dec 22; 183: 812-9.
- Tatemichi S., Kobayashi K., Maezawa A. A1-adrenoceptor subtype selectivity and organ specifi city of silodosin (KMD-3213)//Yakugaku Zasshi., 2006. Mar; 126: 209-16.
- Watson Laboratories Inc. US prescribing information: Rapaflo (silodosin) [online]. Available from URL: http://www.watson. com [Accessed, 2011 Mar 2].
- European Medicines Agency. Summary of product characteristics: Urorec (silodosin) [online]. Available from URL: http://www.ema.europa.eu [Accessed, 2011 Feb 20].
- Wilt T., MacDonald R., Rutks I. Tamsulosin for benign prostatic hyperplasia.//Cochrane Databse of Systematic Reviews, 2003. № 1. Accession Number PUBMED 12535426.
- Marks L.S., Gittelman M.C., Hill L.A. Rapid efficacy of the highly selective A1-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.//J. Urol., 2009 Jun; 181 (6):2634-40.
- European Medicines Agency. CHMP assessment report for Urorec: procedure no EMEA/H/C/001092 [online]. Available from URL: http://www.ema.europa.eu [Accessed, 2011 Mar 2].
- Chapple C.R., Montorsi F., Tammela T.L. Silodosin therapy for lower urinary tract symptoms in men with suspect benign prostatic hyperplasia: results of an international, randomized, double-blind, placeboand active-controlled clinical trial performed in Europe.//Eur Urol, 2011; 59: 342-52.
- Hill L.A. Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study.//Urology, 2009. Dec; 74 (6): 1318-22
- Matsukawa Y., Gotoh M., Komatsu T. Efficacy of for relieving benign prostatic obstruction: prospective pressure flow study.//J Urol, 2009 Dec; 182 (6): 2831-5.
- Montorsi F. Profi le of silodosin. Eur Urol 2010; 4 Suppl. 9:491-5.
- Roehrborn C.G., Kaplan S.A., Lepor H. Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH.//Prostate Cancer Prostatic Dis. Epub, 2010 Dec 7.
- Morganroth J., Lepor H., Hill L.A. Effects of the selective A1-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebocontrolled study.//Clin Pharmacol Ther, 2010 May; 87 (5):609-13
- Curran M.P. Silodosin. Treatment of the symptoms of benign prostatic hyperplasia.//Drugs, 2011; 71 (7): 897-907.
- Buzelin J.M., Hebert M., Blondin P. Alpha-blocking treatment with alfusosin in symptomatic benign prostatic hyperplasia: comparative stydy with prazosin.//Br.J.Urol., 1993. Vol. 72. N6. P.922-927. Accession number PUBMED 0732187.
Статья
